C. Edwards

发表

Release of Oxytocin and Vasopressin by the Human Foetus during Labour

T. Chard, C. Edwards, C. Hudson, 1971, Nature.

Direct inhibition of ovarian steroidogenesis by Cortisol and the modulatory role of 11β‐hydroxysteroid dehydrogenase

P. Curtis, R. Shaw, B. Cooke, 1993, Clinical endocrinology.

11β‐Hydroxysteroid dehydrogenase and enzyme‐mediated receptor protection: Life after liquorice?

B. Walker, C. Edwards, 1991, Clinical endocrinology.

THE KIDNEY IS THE MAJOR SITE OF CORTISONE PRODUCTION IN MAN

J. Whitworth, C. Edwards, P. Stewart, 1989, Clinical endocrinology.

REVERSIBLE INSENSITIVITY TO ANDROGENS IN MEN WITH UNTREATED GLUTEN ENTEROPATHY

C. Edwards, A. Dawson, J. Green, 1977, The Lancet.

Mineralocorticoid excess and inhibition of 11 β‐hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome

B. Walker, C. Edwards, R. Fraser, 1992, Clinical endocrinology.

Glucocorticoid exposure in utero: new model for adult hypertension

R. Benediktsson, J. Seckl, R. Lindsay, 1993, The Lancet.

Placental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure

R. Benediktsson, J. Seckl, A. Calder, 1997 .

Chapter 22 – Vasopressin

C. Edwards, 1977 .

5 α-reductase activity in polycystic ovary syndrome

C. Edwards, C. Shackleton, P. Stewart, 1990, The Lancet.

The stability of tritiated serotonin stored at 4°C - implications for platelet uptake studies

J. Corrie, I. Gow, C. Edwards, 1988 .

cDNA sequence of human β‐preprotachykinin, the common precursor to substance P and neurokinin A

G. Fink, A. Harmar, A. Curtis, 1986, FEBS letters.

A RATIONAL APPROACH FOR ASSESSING THE HYPOTHALAMO-PITUITARY-ADRENAL AXIS

C. Edwards, J. Seckl, P. Padfield, 1988, The Lancet.

HOW EFFECTIVE IS EXTERNAL PITUITARY IRRADIATION FOR GROWTH HORMONE‐SECRETING PITUITARY TUMOURS?

P. Padfield, W. Irvine, C. Feek, 1984, Clinical endocrinology.

Osmotic and non‐osmotic regulation of thirst and vasopressin secretion in patients with compulsive water drinking

P. Baylis, C. Edwards, C. J. Thompson, 1991, Clinical endocrinology.

Potentiation of hydrocortisone activity in skin by glycerrhetinic acid

S. Teelucksingh, M. Greaves, C. Edwards, 1990, The Lancet.

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS: PAST, PRESENT, AND BRIGHT FUTURE

P. Padfield, C. Edwards, 1985, The Lancet.

The Endocrinopathy of Poems Syndrome

P. Stewart, M. Mcintyre, C. Edwards, 1989, Scottish medical journal.

The Integrated Concentration of Cortisone is Reduced in Obese Children

C. Edwards, S. Chalew, D. Burt, 1997, Journal of pediatric endocrinology & metabolism : JPEM.

DEXAMETHASONE‐SUPPRESSIBLEHYPERALDOSTERONISM: STUDIES ON OVERPRODUCTION OF 18‐HYDROXYCORTISOL IN THREE AFFECTED FAMILY MEMBERS

C. Edwards, J. Corrie, M. Sheppard, 1988, Clinical endocrinology.

Fetal osteocalcin levels are related to placental 11β‐hydroxysteroid dehydrogenase activity in humans

R. Benediktsson, J. Seckl, A. Calder, 1995, Clinical endocrinology.

Specificity of the mineralocorticoid receptor crucial role of 11β-hydroxysteroid dehydrogenase

C. Edwards, C. Edwards, O. Steward, 1990, Trends in Endocrinology & Metabolism.

Lithium Carbonate – a Competitive Aldosterone Antagonist?

P. Padfield, P. Stewart, L. Whalley, 1988, British Journal of Psychiatry.

Cerebrospinal Fluid Angiotensin Converting Enzyme Levels in the Diagnosis of Neurosarcoidosis

D. Mitchell, D. B. Horn, C. Edwards, 1991, Scottish medical journal.

Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high‐dose testosterone in patients with partial androgen insensitivity syndrome

P. Saunders, M. Hodgins, D. Tincello, 1997, Clinical endocrinology.

Inactivation of 11β-Hydroxysteroid dehydrogenase type 1 by gene targeting in mice

C. Edwards, J. Seckl, J. Mullins, 1996 .

11 b-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

Edwards, C. Edwards, J. Seckl, 1997 .

Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor.

C. Edwards, E. D. Kloet, P. Stewart, 1988, Lancet.

11 beta-hydroxysteroid dehydrogenase is an exclusive 11 beta- reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations.

C. Edwards, J. Seckl, K. Chapman, 1995, Endocrinology.

Edinburgh Research Explorer Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2

C. Edwards, J. Seckl, J. Mullins, 2022 .

Aldosterone in Cystic Fibrosis: Measurement in Saliva and Correlation with Disease Severity

S. M. Atherden, W. Mccrae, R. Fergusson, 1986, Acta paediatrica Scandinavica.

Sexual dimorphism of hepatic 11 beta-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns.

I. Robinson, C. Edwards, J. Seckl, 1994, The Journal of endocrinology.

Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2.

C. Edwards, J. Seckl, J. Mullins, 1999, The Journal of clinical investigation.

Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess.

B. Walker, C. Edwards, C. Edwards, 1994, Endocrinology and metabolism clinics of North America.

Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring.

C. Edwards, J. Seckl, R. Lindsay, 1996, Hypertension.

11 beta-hydroxysteroid dehydrogenase type 1 expression in 2S FAZA hepatoma cells is hormonally regulated: a model system for the study of hepatic glucocorticoid metabolism.

J. Seckl, K. Chapman, M. Voice, 1996, The Biochemical journal.

11 P-Hydroxysteroid Dehydrogenase in Cultured Hippocampal Cells Reactivates Inert 11 -Dehydrocorticosterone, Potentiating Neurotoxicity

J. Seckl, V. Rajan, C. Edwards, 2003 .

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.

J. Seckl, J. Mullins, D. Schmoll, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Cloning and production of antisera to human placental 11 beta-hydroxysteroid dehydrogenase type 2.

J. Seckl, J. Mullins, Y. Kotelevtsev, 1996, The Biochemical journal.

Human placental 11 beta-hydroxysteroid dehydrogenase: evidence for and partial purification of a distinct NAD-dependent isoform.

C. Edwards, J. Seckl, K. Chapman, 1993, Endocrinology.

Differential promoter usage by the rat 11 beta-hydroxysteroid dehydrogenase gene.

C. Edwards, J. Seckl, M. Moisan, 1992, Molecular endocrinology.